Evidence map›Paper›PMID 35734053›Full record

ArticleLaryngoscope investigative otolaryngology2022

Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with advanced oral cavity cancer.

Pasawat Supanimitjaroenporn, Virat Kirtsreesakul, Manupol Tangthongkum, Peesit Leelasawatsuk, Usaporn Prapaisit

Open access · goldAbstract read
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pasawat SupanimitjaroenpornDepartment of Otolaryngology, Head and Neck Surgery, Faculty of Medicine Prince of Songkla University Hat Yai Thailand.ORCID https://orcid.org/0000-0001-6653-9912
Virat KirtsreesakulDepartment of Otolaryngology, Head and Neck Surgery, Faculty of Medicine Prince of Songkla University Hat Yai Thailand.ORCID https://orcid.org/0000-0002-3338-8975
Manupol TangthongkumDepartment of Otolaryngology, Head and Neck Surgery, Faculty of Medicine Prince of Songkla University Hat Yai Thailand.
Peesit LeelasawatsukDepartment of Otolaryngology, Head and Neck Surgery, Faculty of Medicine Prince of Songkla University Hat Yai Thailand.
Usaporn PrapaisitDepartment of Otolaryngology, Head and Neck Surgery, Faculty of Medicine Prince of Songkla University Hat Yai Thailand.
Prince of Songkla University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lymphocyte-to-monocyte ratio (LMR) has been reported as a prognostic factor in many cancers but the data are to date limited for its use in oral cavity cancer. The purpose of this study was to evaluate the prognostic value of LMR in advanced-stage oral cavity cancer. Methods: Data from 211 advanced-stage oral cancer patients treated with curative intent between January 2009 and December 2015 were obtained from the hospital information system. Pretreatment LMR and other hematologic parameters were recorded and an LMR cutoff value was calculated. Overall survival between the groups above (high LMR) and below (low LMR) the cutoff was compared and hazard ratios from univariate and multivariate analyses using a Cox proportional hazards model calculated. Results: Overall survival and disease-specific survival were better in the high LMR group. The 5-year overall survival rates were 31.6% and 15% in the high LMR and low LMR groups, respectively. Multivariate analysis using a Cox proportional hazards model showed that treatment modality and LMR were the only factors associated with overall survival. Conclusion: Low LMR was associated with poor survival outcome in patients with advanced-stage oral cavity cancer. Level of Evidence: 2b.

Indexed as

lymphocyte‐to‐monocyte ratiooral squamous cell carcinomaprognosis

Identifiers

PMID35734053
PMCPMC9194982
OpenAlexW4220958729

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.